[-] Show simple item record

dc.contributor.authorCadwallader, Karaeng
dc.contributor.authorJankowski, Terry Ann, 1951-eng
dc.date.issued2004eng
dc.description.abstractRate control with long-term anticoagulation is recommended for most patients with atrial fibrillation (strength of recommendation [SOR]: A, based on randomized controlled trials [RCTs]). A rhythm-control strategy provides no survival or quality-of life benefit when compared with rate control and causes more adverse drug effects and increased hospitalizations (SOR: A, based on RCTs).eng
dc.identifier.urihttp://hdl.handle.net/10355/3194eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2004 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 53, no. 07 (July 2004): 581-583.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectrhythmcontrol strategyeng
dc.subjectdrug effectseng
dc.subjectrate controleng
dc.subject.lcshAnticoagulantseng
dc.subject.lcshAtrial fibrillation -- Treatmenteng
dc.titleOther than anticoagulation, what is the best therapy for those with atrial fibrillation?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record